Neos Therapeutics (NEOS) Reports Q2 Loss of $1.65/Share

August 11, 2016 7:06 AM EDT
Get Alerts NEOS Hot Sheet
Trade NEOS Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($1.65), versus ($7.76) reported last year. Revenue for the quarter came in at $1.49 million, versus $1.48 million reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment